InvestorsHub Logo
Followers 1322
Posts 247394
Boards Moderated 55
Alias Born 12/07/2009

Re: None

Wednesday, 08/04/2021 9:17:09 AM

Wednesday, August 04, 2021 9:17:09 AM

Post# of 49
Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain"), a biotechnology company focused on redefining drug discovery by identifying and optimizing novel allosteric binding sites on proteins responsible for neurodegenerative diseases and lysosomal storage disorders, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present a corporate overview at the BTIG Virtual Biotechnology Conference being held on August 9 - 10. $GANX


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GANX News